Gabapentin and Pregabalin for the Treatment of Neuropathic Pain: A Review of Laboratory and Clinical Evidence
Author(s) -
Ian Gilron,
Sarah J.L. Flatters
Publication year - 2006
Publication title -
pain research and management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.702
H-Index - 56
eISSN - 1918-1523
pISSN - 1203-6765
DOI - 10.1155/2006/651712
Subject(s) - pregabalin , gabapentin , neuropathic pain , medicine , postherpetic neuralgia , analgesic , tolerability , neuralgia , allodynia , anesthesia , pain ladder , hyperalgesia , pharmacology , nociception , adverse effect , opioid , receptor , alternative medicine , pathology
1Clinical Pain Research, Departments of Anesthesiology and Pharmacology & Toxicology, Queen’s University, Kingston, Ontario; 2Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Correspondence: Dr Ian Gilron, Clinical Pain Research Departments of Anesthesiology and Pharmacology & Toxicology, Queen’s University, 76 Stuart Street, Kingston, Ontario K7L 2V7. Fax 613-548-1375, e-mail gilroni@post.queensu.ca I Gilron, SJL Flatters. Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Res Manage 2006;11( Suppl A):16A-29A.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom